NanoViricides Inc. (NNVC)

[another_voice_2]

Let's see it my line of reasoning is valid. Since we don't know if, as in my earlier post that multiple doses of EB2 will be tried, what to expect of the test vs the EB1 test.
Lets say the 100% dose killed in 5 days.
The EB1 animals lived 6.5 days(?), a 30% extension of life.
The multiple EB2 candidates find one or more with a 7.5 day extension.
Would this be considered success?
Would you suggest changing the protocol to include multiple dose until remission or death occurs(if this isn't a part of the testing now)?